Effects of combining lowdose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome

Molecular Medicine Reports

Volumn 10, Issue 5, 2014, Pages 2372-2376

  Zhao, Yue ^a   Du, Botao ^a   Jiang, Xiaoying ^b   Ma, Mingxing ^a   Shi, Liqing ^a   Zhang, Qinxi ^a   Zhou, Lili ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Red Cross Central Hospital   (China)

Author keywords

Aspirin; Polycystic ovary syndrome; Pulsatility index; Resistance index; Tiao Jing Cu Yun pills

Indexed keywords

ACETYLSALICYLIC ACID; CHINESE DRUG; CHORIONIC GONADOTROPIN; LETROZOLE; TIAO JING CU YUN PILL; UNCLASSIFIED DRUG; FERTILITY PROMOTING AGENT; HERBACEOUS AGENT; NITRILE; TIAO JING CU YUN; TRIAZOLE DERIVATIVE;

ADULT; ARTERY BLOOD FLOW; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; END DIASTOLIC VELOCITY; ENDOMETRIAL THICKNESS; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OOCYTE; OVARY POLYCYSTIC DISEASE; PEAK SYSTOLIC VELOCITY; PERIFOLLICULAR BLOOD FLOW; PERIPHERAL CIRCULATION; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY; DRUG COMBINATION; DRUG EFFECTS; ECHOGRAPHY; ENDOMETRIUM; INFERTILITY, FEMALE; OVARY FOLLICLE; PATHOLOGY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; VASCULARIZATION; YOUNG ADULT;

ADULT; ASPIRIN; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; ENDOMETRIUM; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; NITRILES; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; TRIAZOLES; YOUNG ADULT;

EID: 84907210430     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2570     Document Type: Article

References (23)

1. Archer JS and Chang RJ: Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18: 737-754, 2004.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES and Yildiz BO: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745-2749, 2004.
3. Hu WH, Qiao J, Wang LN and Tong J: Clinical features of the metabolic syndrome in patients with polycystic ovary syndrome. Beijing Da Xue Xue Bao 42: 159-163, 2010 (In Chinese).
4. Nahid L and Sirous K: Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol 64: 253-258, 2012.
5. Nahid L and Sirous K: Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol 64: 253-258, 2012.
6. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reprod 19: 41-47, 2004.
7. Azziz R, Carmina E, Dewailly D, et al; Androgen Excess Society: Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91: 4237-4245, 2006.
8. Health industry standard of the People's Republic: Diagnosis of the polycystic ovary syndrome (WS 330-2011). The Ministry of Health Medical Service Standard Professional Committee of the People's Republic of China, 2011.
9. Zhang XN: Research on uterine and ovarian arterial blood flow for kidney-tonification and blood stasis-elimination treatment of polycystic ovarian syndrome. Chin J Pract Med 26: 864-867, 2010 (In Chinese).
10. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23: 462-477, 2008.
11. Goldenberg N and Glueck C: Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation. Minerva Ginecol 60: 63-75, 2008.
12. Borini A, Maccolini A, Tallarini A, Bonu MA, Sciajno R and Flamigni C: Perifollicular vascularity and its relationship with oocyte maturity and IVF outcome. Ann NY Acad Sci 943: 64-67, 2001.
13. Jokubkiene L, Sladkevicius P, Rovas L and Valentin L: Assessment of changes in volume and vascularity of the ovaries during the normal menstrual cycle using three-dimensional power Doppler ultrasound. Hum Reprod 21: 2661-2668, 2006.
14. Otsuki J, Okada A, Morimoto K, Nagai Y and Kubo H: The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes. Hum Reprod 19: 1591-1597, 2004.
15. Kurjak A, Kupesic-Urek S, Schulman H and Zalud I: Transvaginal color flow Doppler in the assessment of ovarian and uterine blood flow in infertile women. Fertil Steril 56: 870-873, 1991.
16. Du B, Takahashi K, Ishida GM, Nakahara K, Saito H and Kurachi H: Usefulness of intraovarian artery pulsatility and resistance indices measurement on the day of follicle aspiration for the assessment of oocyte quality. Fertil Steril 85: 366-370, 2006.
17. Ozturk O, Greaves M and Templeton A: Aspirin dilemma. Remodelling the hypothesis from a fertility perspective. Hum Reprod 17: 1146-1148, 2002.
18. Saito H, Kaneko T, Kawachiya S, Du B, Ishida GM and Kurachi H: Effects of aspirin on the oocyte quality. Fertil Steril 76: S131, 2001.
19. Patrono C, Garca Rodrguez LA, Landolfi R and Baigent C: Low-dose aspirin for the prevention of atherosclerosis. N Engl J Med 353: 2373-2383, 2005.
20. Daya S: Is there a benefit of low-dose aspirin in assisted reproduction? Curr Opin Obstet Gynecol 18: 313-318, 2006.
21. Lai Q: 96 cases of clinical observation on Tiao Jing Cu Yun pills treatment for ovulation inhibition. Chin J Cosmetic Med 20: 353, 2011.
22. Xu ZM, Zhou YH and Peng JY: Curative effect observation on Tiao Jing Cu Yun pills for polycystic ovarian syndrome. Chin J Shanxi Trad Chi Med 27: 18-19, 2004 (In Chinese).
23. Isaacs JD Jr, Wells CS, Williams DB, Odem RR, Gast MJ and Strickler RC: Endometrial thickness is a valid monitoring parameter in cycles of ovulation induction with menotropins alone. Fertil Steril 65: 262-266, 1996.